Cardiology

Effective preventive strategies are needed to reduce cardiovascular disease, the leading cause of mortality and morbidity globally.

The analysis of lipid profiling in the prediction of risk of developing type 2 diabetes and cardiovascular diseases can aid in recommending lifestyle changes and diet before the development of the diseases.

Studies have found that average levels of moderate caffeine intake are related to lower cardiovascular risk.

Data suggest that fewer than twenty percent of patients with type 2 diabetes are lowering their risk of heart disease, prompting prominent doctors to demand immediate action. 

Consumption of fish oil plus DASH diet is associated with a partial alteration in lipid metabolism and inflammatory mediators in patients with T2D. 

Data analysis suggests the need to create CVD prediction models specifically focused on the risk factors that affect patients with type 2 diabetes. 

Patients with cardiac implantable electronic devices (CIEDs) who received an SGLT2i had a significantly lower incidence of atrial arrhythmia (AA) compared to placebo. 

Trials tested the hypothesis that treating patients with intensive therapy to target normal glycated hemoglobin A1c levels would positively affect cardiovascular risk. 

Baseline hemoglobin A1C may be inversely proportional to the risk of statin-induced new-onset diabetes. 

Diabetes or prediabetes may put a patient at higher risk of developing cardiovascular diseases.